Portal Hypertension Market Summary
- The Portal Hypertension Market is witnessing steady growth driven by rising liver disease prevalence, advancements in diagnostic and therapeutic approaches, and increasing awareness of early management strategies.
- The leading Portal Hypertension Companies such as Gilead Sciences, Inc, LinXis B.V, Mezzion Pharma Co. Ltd, Intercept Pharmaceuticals, Inc, Conatus Pharmaceuticals Inc, Galectin Therapeutics, Inc, Ono Pharmaceutical Co., Ltd, and others.
Request for Unlocking the Sample Page of the "Portal Hypertension Treatment Market"
Key Factors Driving the Portal Hypertension Market Growth
-
Rising Prevalence of Liver Diseases
The increasing global burden of chronic liver conditions—such as cirrhosis, hepatitis B and C infections, and non-alcoholic fatty liver disease (NAFLD/NASH)—is a major driver of the portal hypertension market. These diseases are primary causes of elevated portal venous pressure, leading to greater demand for effective management options.
-
Advancements in Diagnostic Techniques
Innovations in non-invasive diagnostic tools, including transient elastography, Doppler ultrasound, and MRI-based assessments, have improved early detection and monitoring of portal hypertension, enhancing patient outcomes and fueling market growth.
-
Growing Adoption of Targeted Therapies
Increased focus on developing novel pharmacological agents—such as vasoactive drugs, beta-blockers, and antifibrotic therapies—has expanded treatment options and is driving market expansion.
-
Increasing Awareness and Screening Programs
Global initiatives and awareness campaigns by healthcare organizations are encouraging early diagnosis and management of liver-related disorders, indirectly supporting the demand for portal hypertension therapies.
DelveInsight’s “Portal Hypertension Treatment Market Insights, Epidemiology, and Market Forecast – 2032” report delivers an in-depth understanding of Portal Hypertension, historical and forecasted epidemiology as well as the Portal Hypertension market trends in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom, and Japan.
The Portal Hypertension Treatment Market Report provides current treatment practices, emerging drugs, Portal Hypertension market share of individual therapies, and current and forecasted Portal Hypertension market size from 2019 to 2032, segmented by the seven major markets. The report also covers current Portal Hypertension treatment practices/algorithms and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
|
Study Period |
2019 to 2032 |
|
Forecast Period |
2023-2032 |
|
Geographies Covered |
|
|
Portal Hypertension Market |
|
|
Portal Hypertensions Market Size | |
|
Portal Hypertension Companies |
|
|
Portal Hypertension Epidemiology Segmentation |
|
Portal Hypertension Treatment Market
DelveInsight’s Portal Hypertension market report gives a thorough understanding of Portal Hypertension by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment.
Portal Hypertension Overview
Portal Hypertension is an increase in the pressure within the portal vein (the vein that carries blood from the digestive organs to the liver). The increase in pressure is caused by a blockage in the blood flow through the liver. Increased pressure in the portal vein causes large veins (varices) to develop across the esophagus and stomach to get around the blockage. The varices become fragile and can bleed easily. The most common cause of Portal Hypertension is cirrhosis or scarring of the liver. Cirrhosis is known to result from the healing of a liver injury caused by hepatitis, alcohol abuse, or other causes of liver damage. In cirrhosis, the scar tissue blocks blood flow through the liver and slows its processing functions.
Portal Hypertension Diagnosis
Portal Hypertension can be diagnosed in several ways. Clinical diagnosis can be made in the setting of end-stage liver disease and in the presence of ascites and/or varices. Subclinical Portal Hypertension is much more difficult to diagnose, but low platelet levels, a large portal vein, and splenic enlargement on imaging studies are suggestive. Direct or indirect measurements of the portal vein may be accomplished using wedged hepatic vein pressure or splenic pulp pressure, but these methods are relatively invasive.
Portal Hypertension Treatment
The effects of Portal Hypertension can be managed through diet, medications, endoscopic therapy, surgery, or radiology. Once the bleeding episode has been stabilized, treatment options are prescribed based on the severity of the symptoms and on how well the patient’s liver is functioning. Management of Portal Hypertension depends on its cause, and if there are reversible causes, the clinician should attempt to correct them.
Portal Hypertension Epidemiology
The Portal Hypertension epidemiology section provides insights into the historical and current Portal Hypertension patient pool and forecasted trends for seven individual major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Portal Hypertension report also provides the diagnosed patient pool, their trends and, assumptions undertook.
Key findings from the Portal Hypertension Epidemiological Analysis
- According to the National Institute of Health, in the United States, 2,000 per 100,000 people have liver cirrhosis and that more than 90% of individuals with cirrhosis develop Portal Hypertension.
- The Portal Hypertension epidemiology covered in the report provides historical as well as forecasted Portal Hypertension epidemiology [segmented as Total Incident Cases of Portal Hypertension, Cause-specific Cases of Portal Hypertension, Gender-specific Cases of Portal Hypertension, Age-specific Cases of Portal Hypertension, and Treatable Cases of Portal Hypertension] in the 7MM covering the United States, EU4 countries (Germany, France, Italy, Spain) and the United Kingdom, and Japan from 2019 to 2032.
Portal Hypertension Epidemiology Segmentation
- Total Portal Hypertension Incident Cases
- Portal Hypertension Cause-specific Cases
- Portal Hypertension Gender-specific Cases
- Portal Hypertension Age-specific Cases
- Portal Hypertension Treatable Cases
Portal Hypertension Market Recent Breakthroughs
- In April 2025, Galectin Therapeutics Inc. announced the initiation of a Phase 2b/3 clinical trial designed to evaluate the efficacy, safety, and tolerability of belapectin versus placebo in patients with nonalcoholic steatohepatitis (NASH) cirrhosis who exhibit clinical evidence of portal hypertension but have no esophageal varices at baseline.
Portal Hypertension Drug Analysis
The drug chapter segment of the Portal Hypertension Therapeutics Market Report encloses a detailed analysis of Portal Hypertension marketed drugs and late-stage (Phase III and Phase II) Portal Hypertension pipeline drugs. It also helps understand the Portal Hypertension clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug, and the latest news and press releases.
Portal Hypertension Emerging Drugs
The report details the emerging Portal Hypertension therapies under the late and mid-stage of development for Portal Hypertension treatment.
-
Belapectin: Galectin Therapeutics Inc.
Galectin Therapeutics Inc. is developing Belapectin (also known as GR-MD-02), a complex carbohydrate drug that targets galectin-3, a critical protein in the pathogenesis of fatty liver disease and fibrosis. The Phase IIb NASH-CX trial of the use of belapectin in treating patients with NASH cirrhosis showed statistically significant and clinically meaningful results in reducing HVPG (hepatic venous pressure gradient) in comparison to placebo in NASH cirrhosis patients without esophageal varices, which represented 50% of the patients enrolled in the clinical trial. Belapectin could improve Portal Hypertension and potentially prevent the development of esophageal varices in NASH cirrhosis and subsequent complications
Portal Hypertension Market Outlook
The Portal Hypertension market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Portal Hypertension market trends by analyzing the impact of current therapies on the market, unmet needs, and demand for better technology. This segment gives a thorough detail of the Portal Hypertension market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need for the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
The emerging pipeline for the Portal Hypertension Treatment is not robust. A very few candidates are being investigated by pharmaceuticals companies in this disease area. According to DelveInsight, the Portal Hypertension market in the 7MM is expected to witness a major change in the study period 2019–2032.
Key findings
This section includes a glimpse of the Portal Hypertension Drugs Market in the 7MM.
The United States: Portal Hypertension Market Outlook
This section provides the total Portal Hypertension market size and market size by therapies in the United States.
EU4 and the UK: Portal Hypertension Market Outlook
The total Portal Hypertension market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom are provided in this section.
Japan: Portal Hypertension Market Outlook
The total Portal Hypertension market size and market size by therapies in Japan are also mentioned.
Portal Hypertension Drug Uptake
This section focuses on the rate of uptake of the potential drugs recently launched in the Portal Hypertension market or expected to get launched in the market during the study period 2019–2032. The analysis covers Portal Hypertension market uptake by drugs, patient uptake by therapies, and sales of each drug. This will help in understanding the Portal Hypertension drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in the market uptake and in making financial and regulatory decisions.
Portal Hypertension Pipeline Development Activities
The report provides insights into different Portal Hypertension clinical trials within Phase II, and Phase III stages. It also analyses Portal Hypertension’s Companies involved in developing targeted therapeutics. The report covers detailed information on collaborations, acquisitions, and mergers, licensing patent details, and other information on Portal Hypertension emerging therapies.
Portal Hypertension Reimbursement Scenario
Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we consider reimbursement to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.
Latest KOL-Views on Portal Hypertension
To keep up with current epidemiology and market trends, we take KOLs and SMEs' opinions working in the Portal Hypertension domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies and treatment patterns along with Portal Hypertension market trends. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the market and the unmet needs.
Portal Hypertension Competitive Intelligence Analysis
We perform competitive and market intelligence analysis of the Portal Hypertension market by using various competitive intelligence tools that include – SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies, etc. The inclusion of the analysis entirely depends upon the data availability.
Scope of the Portal Hypertension Market Report
- Descriptive overview of the Portal Hypertension, disease overview, patient journeys, treatment algorithms, diagnosis, and currently available therapies
- Comprehensive insight into the Portal Hypertension epidemiology and forecasts in the 7MM
- An all-inclusive account of both the current and Portal Hypertension Emerging Therapies, along with the assessment of new therapies, expected to have an impact on the current treatment landscape
- Exhaustive analysis of the Portal Hypertension Treatment Market, historical and forecasted, covering drug outreach in the 7MM
- Trends shaping and driving the global Portal Hypertension therapeutics market
Portal Hypertension Market Report Highlights
- In the coming years, the Portal Hypertension market is set to change due to the the increasing incident cases of Portal Hypertension and the expected launch of upcoming therapies; which would expand the size of the market
- The Portal Hypertension Companies and academics are working to assess challenges and seek opportunities that could influence Portal Hypertension R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
- Major Portal Hypertension Companies are involved in developing Portal Hypertension therapies. The launch of emerging therapies will significantly impact the Portal Hypertension market
- A better understanding of Portal Hypertension pathogenesis will also contribute to the development of novel therapeutics for the Portal Hypertension
- Our in-depth analysis of the Portal Hypertension pipeline assets across different stages of development (Phase III and Phase II), emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities
Portal Hypertension Market Report Insights
- Patient-based Portal Hypertension Market Forecasting
- Portal Hypertension Therapeutic approaches
- Portal Hypertension pipeline analysis
- Portal Hypertension market size and trends
- Portal Hypertension market opportunities
- Impact of upcoming Portal Hypertension therapies
Portal Hypertension Market Report Key Strengths
- 10-year Portal Hypertension Market Forecast
- The 7MM coverage
- Portal Hypertension epidemiology segmentation
- Key cross competition
- KOL views
- Portal Hypertension drugs uptake
Portal Hypertension Market Report Assessment
- Current Portal Hypertension Treatment Practices
- Portal Hypertension Unmet Needs
- Portal Hypertension pipeline product profiles
- Portal Hypertension market attractiveness
- Portal Hypertension Market Drivers
- Portal Hypertension Market Barriers
Key Questions Answered In The Portal Hypertension Market Report:
Portal Hypertension market insights:
- What would be the Portal Hypertension market growth till 2032, and what will be the resultant market size in 2032?
- What was the Portal Hypertension drug class share (in percentage) distribution in 2019, and how would it look in 2032?
- What would be the Portal Hypertension total market size and market size by therapies across the 7MM during the forecast period (2023–2032)?
- What are the key findings of the market across the 7MM, and which country will have the largest Portal Hypertension market size during the forecast period (2023–2032)
- How would the unmet needs affect the Portal Hypertension market dynamics and subsequent analysis of the associated trends?
Portal Hypertension Epidemiology Insights:
- What are the disease risk, burden, and regional/ethnic differences of Portal Hypertension?
- What is the historical and forecasted Portal Hypertension patient pool in the 7MM, and where can one observe the highest patient population and growth opportunities?
- What are the key factors driving the epidemiology trends for the seven major markets covering the United States, EU4 (Germany, Spain, France, Italy) and the UK, and Japan?
- ent Treatment Scenario, Marketed Drugs, and Emerging Therapies
- What are the current treatment guidelines and treatment options, in addition to approved therapies for Portal Hypertension in the US, Europe, and Japan?
- What are the key collaborations (Industry–Industry, Industry-Academia), mergers and acquisitions, and licensing activities related to Portal Hypertension therapies?
- What are the recent novel therapies, targets, mechanisms of action, and technologies being developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Portal Hypertension and its status, along with the challenges faced?
Reasons to Buy the Portal Hypertension Market Forecast Report
- The Portal Hypertension Therapeutics Market Report will help in developing business strategies by understanding trends shaping and driving the Portal Hypertension market
- Organize sales and marketing efforts by identifying the best opportunities for Portal Hypertension in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
- Identification of strong upcoming players in the Portal Hypertension Drugs Market that will help devise strategies that will help in getting ahead of competitors.
Stay updated with us for Recent Articles @ New DelveInsight Blogs
